ロード中...
CAR T-cell therapy for pleural mesothelioma: rationale, preclinical development, and clinical trials
The aim of adoptive T-cell therapy is to promote tumor-infiltrating immune cells following the transfer of either tumor-harvested or genetically engineered T lymphocytes. A new chapter in adoptive T-cell therapy began with the success of chimeric antigen receptor (CAR) T-cell therapy. T cells harves...
保存先:
| 出版年: | Lung Cancer |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184643/ https://ncbi.nlm.nih.gov/pubmed/33972125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2021.05.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|